Fusion Pharm Net Income Over Time
| FSPM Stock | USD 0.0001 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Fusion Pharm Performance and Fusion Pharm Correlation. Will Consumer Staples Distribution & Retail sector continue expanding? Could Fusion diversify its offerings? Factors like these will boost the valuation of Fusion Pharm. Market participants price Fusion higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fusion Pharm data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fusion Pharm's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Fusion Pharm and related stocks such as Bimi International, Bionik Laboratories Corp, and Islet Holdings Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIMI | (331 K) | 2 M | 88 K | (180 K) | (617 K) | (969 K) | (1.8 M) | (1.6 M) | (16.8 M) | (4.4 M) | (5.3 M) | (35 M) | (22.4 M) | (10.5 M) | (10.5 M) | (9.5 M) | (9 M) |
| GRPI | (153.9 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (55.6 K) | (50 K) | (47.5 K) |
| OHAQ | 1.1 K | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 8.5 M | 5.3 M |
Fusion Pharm and related stocks such as Bimi International, Bionik Laboratories Corp, and Islet Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Fusion Pharm financial statement analysis. It represents the amount of money remaining after all of Fusion Pharm operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Fusion Pharm | FSPM |
Specialization | Consumer Staples, Consumer Staples Distribution & Retail |
| Business Address | 5850 East 58th |
| Exchange | OTCCE Exchange |
USD 1.0E-4
Check out Fusion Pharm Performance and Fusion Pharm Correlation. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Fusion Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.